264 related articles for article (PubMed ID: 19543906)
1. Visualizing vitreous in vitrectomy by triamcinolone.
Sakamoto T; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1153-63. PubMed ID: 19543906
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
[TBL] [Abstract][Full Text] [Related]
3. Triamcinolone-assisted pars plana vitrectomy for retinal disease.
Zheng Y; Sun N; Xiong Q; Wang X; Quan Y
Yan Ke Xue Bao; 2005 Sep; 21(3):142-6. PubMed ID: 17162851
[TBL] [Abstract][Full Text] [Related]
4. Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole.
Yamamoto N; Ozaki N; Murakami K
Ophthalmologica; 2004; 218(4):248-56. PubMed ID: 15258413
[TBL] [Abstract][Full Text] [Related]
5. Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane.
Matsumoto H; Yamanaka I; Hisatomi T; Enaida H; Ueno A; Hata Y; Sakamoto T; Ogino N; Ishibashi T
Retina; 2007 Feb; 27(2):174-9. PubMed ID: 17290199
[TBL] [Abstract][Full Text] [Related]
6. Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy.
Doi N; Uemura A; Nakao K; Sakamoto T
Retina; 2005 Sep; 25(6):742-5. PubMed ID: 16141862
[TBL] [Abstract][Full Text] [Related]
7. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.
Sonoda KH; Sakamoto T; Enaida H; Miyazaki M; Noda Y; Nakamura T; Ueno A; Yokoyama M; Kubota T; Ishibashi T
Ophthalmology; 2004 Feb; 111(2):226-30. PubMed ID: 15019367
[TBL] [Abstract][Full Text] [Related]
8. One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy.
Yamakiri K; Sakamoto T; Noda Y; Nakahara M; Ogino N; Kubota T; Yokoyama M; Furukawa M; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2008 Jul; 246(7):959-66. PubMed ID: 18431588
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hyaloid-retinal relationship during triamcinolone-assisted vitrectomy for primary rhegmatogenous retinal detachment.
Sundar D; Takkar B; Venkatesh P; Chawla R; Temkar S; Azad SV; Vohra R
Eur J Ophthalmol; 2018 Sep; 28(5):607-613. PubMed ID: 29569478
[TBL] [Abstract][Full Text] [Related]
10. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy.
Yamakiri K; Sakamoto T; Noda Y; Nakahara M; Ogino N; Kubota T; Yokoyama M; Furukawa M; Sonoda Y; Yamada T; Doi N; Enaida H; Hata Y; Ishibashi T
Ophthalmology; 2007 Feb; 114(2):289-96. PubMed ID: 17270679
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of vitrectomy with triamcinolone assistance versus internal limiting membrane peeling for highly myopic macular hole retinal detachment.
Wei Y; Wang N; Zu Z; Bi C; Wang H; Chen F; Yang X
Retina; 2013 Jun; 33(6):1151-7. PubMed ID: 23508079
[TBL] [Abstract][Full Text] [Related]
12. Triamcinolone acetonide-assisted peeling of the internal limiting membrane.
Kimura H; Kuroda S; Nagata M
Am J Ophthalmol; 2004 Jan; 137(1):172-3. PubMed ID: 14700661
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
Jonas JB; Söfker A; Degenring R
Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
[TBL] [Abstract][Full Text] [Related]
14. VITRECTOMY WITHOUT INNER LIMITING MEMBRANE PEELING FOR MACULAR RETINOSCHISIS IN HIGHLY MYOPIC EYES.
Qi Y; Duan AL; Meng X; Wang N
Retina; 2016 May; 36(5):953-6. PubMed ID: 26529553
[TBL] [Abstract][Full Text] [Related]
15. Safety of Triamcinolone acetonide (TA)-assisted pars plana vitrectomy in macular hole surgery.
Kampougeris G; Cheema R; McPherson R; Gorman C
Eye (Lond); 2007 May; 21(5):591-4. PubMed ID: 16456587
[TBL] [Abstract][Full Text] [Related]
16. Filter connected with three-way cock in remove of the vehicle in triamcinolone acetonide.
Du L; Xing Y; Chen C
Yan Ke Xue Bao; 2006 Sep; 22(3):156-9, 165. PubMed ID: 17162900
[TBL] [Abstract][Full Text] [Related]
17. [Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide].
Mańkowska A; Rejdak R; Oleszczuk A; Kiczyńska M; Łekawa A; Choragiewicz T; Zagórski Z
Klin Oczna; 2008; 110(4-6):151-4. PubMed ID: 18655452
[TBL] [Abstract][Full Text] [Related]
18. Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.
Lee Y; Kang S; Park YH
Korean J Ophthalmol; 2013 Feb; 27(1):28-33. PubMed ID: 23372376
[TBL] [Abstract][Full Text] [Related]
19. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.
Sonoda KH; Enaida H; Ueno A; Nakamura T; Kawano YI; Kubota T; Sakamoto T; Ishibashi T
Br J Ophthalmol; 2003 Aug; 87(8):1010-4. PubMed ID: 12881346
[TBL] [Abstract][Full Text] [Related]
20. Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide.
Higuchi A; Ogata N; Jo N; Wada M; Matsumura M
Jpn J Ophthalmol; 2006; 50(6):529-531. PubMed ID: 17180527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
